Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rigon

Showing results (861-870 of 863) with videos related to

Pageof 87
Sort By:
You have reached the last page of results.This site can display upto 863 results.
Cancer Cell|April 20, 2013
Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric propertiesFrançoise Bono, Frederik De Smet, Corentin Herbert, et al.
Eclinicalmedicine|March 30, 2022
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study groupOlivier Hermine, Xavier Mariette, Raphael Porcher, et al.
International Journal of Bipolar Disorders|September 26, 2019
Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiativeJan Scott, Diego Hidalgo-Mazzei, Rebecca Strawbridge, et al.
Pageof 87

Showing results (861-870 of 863) with videos related to

Sort By:
Pageof 87
You have reached the last page of results.This site can display upto 863 results.
Cancer Cell|April 20, 2013
Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric propertiesFrançoise Bono, Frederik De Smet, Corentin Herbert, et al.
Eclinicalmedicine|March 30, 2022
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study groupOlivier Hermine, Xavier Mariette, Raphael Porcher, et al.
International Journal of Bipolar Disorders|September 26, 2019
Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiativeJan Scott, Diego Hidalgo-Mazzei, Rebecca Strawbridge, et al.
Pageof 87